Group Post |
Fourteen countries and European Commission express concern about WHO Covid-19 origin report |
mike kraft |
Group Post |
With the US making no progress on average daily Covid-19 cases last month, officials fear a coming crisis |
mike kraft |
Group Post |
When young children test positive for Covid-19 and another respiratory virus, their illness may be much more severe--new study |
mike kraft |
Group Post |
Sanofi, GSK variant-specific COVID vaccine reported effective against Omicron |
mike kraft |
Group Post |
The U.N.'s Covax is likely to deliver less than half of the promised 2 billion vaccine doses to help the world’s neediest icountries in 2021. |
mike kraft |
Group Post |
State Department report says predators world wide took advantage of the pandemic lockdowns |
mike kraft |
Group Post |
EU ambassador says Russia delays EMA Sputnik V vaccine inspections - media report |
mike kraft |
Group Post |
U.S. considering larger role in global vaccination efforts |
mike kraft |
Group Post |
An expert explains how to prepare for possible COVID-19 surge --CNN Analyst |
mike kraft |
Group Post |
Omicron now dominant strain of coronavirus in the U.S, 73% of new cases |
mike kraft |
Group Post |
COVID-19 deaths in Africa surge 43% week-on-week-- WHO |
mike kraft |
Group Post |
WHO-led program proposes to buy antiviral COVID-19 pills for $10 for poorer countries |
mike kraft |
Group Post |
EU reportedly preparing legal case against AstraZeneca over vaccine shortfalls |
mike kraft |
Group Post |
Asia keeps omicron at bay for now, but worries about a surge that already hit Australia |
mike kraft |
Group Post |
Russia's Sputnik V shot around 83% effective against Delta variant, lower than previous estimate |
mike kraft |
Group Post |
Overview: Pandemic developments in Europe, Asia, Australia |
mike kraft |
Group Post |
Vaccines linked to rare clotting disorders--an analysis |
mike kraft |
Group Post |
Rapid testing for Omicron: some experts and FDA disagree on whether throat swabbing shouldbe used |
mike kraft |
Group Post |
Effective treatments for COVID are now available. Why are they not being used? |
mike kraft |
Group Post |
Rates of Covid-19 hospitalizations for children and adults under 50 reach their highest levels yet -- CDC data |
mike kraft |
Group Post |
U.S. FDA proposes major shift to annual COVID vaccine strategy--one shot annually |
mike kraft |
Group Post |
Inovio lab tests show COVID vaccine weaker against Omicron, study focus to change |
mike kraft |
Group Post |
Now is the time to get vaccinated, as the holidays – and respiratory virus season – ramp up |
mike kraft |
Group Post |
OVERVIEW: U.S., Asia, Canandian developments |
mike kraft |
Group Post |
A fourth Moderna covid shot may eventuallty be needed as efficacy of boosters likely to decline over time |
mike kraft |
Recent Comments